³í¹®) õ¿¬À¯·¡ ´Ú³ª¹« ¼ººÐ ¿øÇü±×´ë·Î ¸ð»çÇÑ ½Å¹°Áú 'AP736' ¹Ì¹é È¿°ú È®ÀÎ
¿µ¹®) Antimelanogenic activity of a novel adamantyl benzylbenzamide derivative, AP736: a randomized, double-blind, vehicle-controlled comparative clinical trial performed in patients with hyperpigmentation during the summer